KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Dec 23, 2019 $3.76 $4.22 $3.76 $3.92 545 920
Dec 20, 2019 $3.06 $3.99 $3.05 $3.84 1 753 187
Dec 19, 2019 $2.72 $2.96 $2.72 $2.96 351 900
Dec 18, 2019 $2.76 $2.88 $2.70 $2.75 102 045
Dec 17, 2019 $2.88 $2.88 $2.71 $2.80 142 680
Dec 16, 2019 $2.80 $2.88 $2.73 $2.85 169 509
Dec 13, 2019 $2.71 $2.80 $2.66 $2.75 90 530
Dec 12, 2019 $2.70 $2.77 $2.65 $2.69 151 779
Dec 11, 2019 $2.73 $2.79 $2.69 $2.71 62 593
Dec 10, 2019 $2.74 $2.89 $2.66 $2.73 59 767
Dec 09, 2019 $2.90 $2.97 $2.71 $2.72 122 486
Dec 06, 2019 $2.99 $3.07 $2.87 $2.87 109 802
Dec 05, 2019 $3.05 $3.06 $2.85 $2.98 135 694
Dec 04, 2019 $2.81 $3.08 $2.81 $3.02 207 692
Dec 03, 2019 $2.61 $2.81 $2.61 $2.77 121 203
Dec 02, 2019 $2.72 $2.82 $2.70 $2.75 89 845
Nov 29, 2019 $2.85 $2.85 $2.73 $2.74 76 107
Nov 27, 2019 $2.73 $2.85 $2.73 $2.80 67 620
Nov 26, 2019 $2.81 $2.83 $2.71 $2.75 32 704
Nov 25, 2019 $2.69 $2.85 $2.69 $2.80 110 053
Nov 22, 2019 $2.77 $2.82 $2.70 $2.73 72 781
Nov 21, 2019 $2.83 $2.87 $2.71 $2.77 100 361
Nov 20, 2019 $2.89 $3.05 $2.75 $2.81 88 549
Nov 19, 2019 $2.79 $2.95 $2.77 $2.90 66 070
Nov 18, 2019 $2.80 $2.83 $2.79 $2.81 85 070
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT